Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Leukemia × Antibodies, Monoclonal × Clear all

Phase

Status

Unknown 1 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia 1 Glioblastoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1

Interventions

Cytarabine 36 Cyclophosphamide 27 Etoposide 18 Radiotherapy 17 Daunorubicin 17 Methotrexate 15 Busulfan 15 Peripheral Blood Stem Cell Transplantation 14 Idarubicin 14 Mercaptopurine 13 Dexamethasone 13 Vincristine 12 Thioguanine 10 Mitoxantrone 9 Doxorubicin 9 pegaspargase 8 Asparaginase 8 Antilymphocyte Serum 8 fludarabine phosphate 7 Prednisolone 7 Polymerase Chain Reaction 7 Filgrastim 7 Cyclosporine 7 Prednisone 6 Mycophenolic Acid 5 Melphalan 5 Leucovorin 5 Gene Expression Profiling 5 Vindesine 4 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00515892 2007-08-14

NHL

Cambridge Antibody Technology

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡